皇冠体育app

The first anti-bird flu vaccine made in 皇冠体育app is safe for human use, its maker Sinovac Biotech claimed yesterday.

The immunity vaccine was developed jointly by Sinovac Biotech, the first to come up with an anti-SARS vaccine, and the Chinese Center for Disease Control and Prevention. The Ministry of Science and Technology and the Ministry of Health supported the program.

Sionovac Boitech division leader Yin Xiaomei said the results of the second clinical tests "have proved" the vaccine's major index is up to international standards. It has yielded positive results in humans.